INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 270
RESEARCH DOSSIER / NOT AN ENDORSEMENT

Superpower

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

'Your new health membership. Members get 100+ lab tests from one blood draw. $199 per year.' Detect 1,000+ conditions; 6M+ biomarkers analyzed; HSA/FSA eligible. 'What could cost $10,000 is now $199.' Membership includes AI chat (Kin), 24/7 care team, wearable connections, and access to add-on tests, peptides, supplements and prescriptions.

Audienceread

Our read: health-optimization and longevity-focused US consumers; employer offering ('For Employers') also listed. No targeting inferred.

Pricing & termssnapshot

Membership $199/year including 100+ biomarker lab tests; add-on tests (gut, toxins, Grail Galleri cancer screen) extra. TechCrunch reported a $499 price at public launch (Apr 2025), so the current $199 reflects a price change.

Clinical relationshipspartial

Care team access 24/7 included; prescribing arrangements behind membership not reviewed in this pass.

Pharmacy & fulfillmentpartial

Blood draw network for baseline testing; pharmacy/lab partners not reviewed in this pass.

Advertising snapshotpartial

Google lookup displayed 93 ads (US, last 30 days) on 20 Oct 2026; Meta shows ~720 active US ads on the Superpower Health page (bodies age-gated); LinkedIn's 93 fuzzy matches are unrelated advertisers. See dated channel evidence.

Founding yearpartial

Publicly launched April 2025 with a $30M Series A led by Forerunner Ventures.

Foundersverified

Co-founders Max Marchione (CEO), Kevin Unkrich and Jacob Peters.

Location & entity contextnot_found

Not captured in this pass.

    Search visibility samplenot_found

    Not assessed in this pass.

      THE MODERN DOSING WEEKLY

      The peptide news
      that changes your week.

      Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.